Savara Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Savara Inc. on December 14, 2017. The filing details Item 5.02 regarding the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. The changes were approved by the Board of Directors upon the recommendation of the Compensation Committee to align executive compensation with the company's transition to a publicly held entity following its merger with Mast Therapeutics Inc. in April 2017.
Key Financial Metrics and Compensation Adjustments
The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on executive and director compensation adjustments effective December 16, 2017, and bonus awards for 2017 performance.
| Executive Officer | Title | New Annual Base Salary | 2018 Target Bonus | 2018 Bonus % of Base |
|---|---|---|---|---|
| Rob Neville | Chief Executive Officer | $525,000 | $262,000 | 50% |
| Taneli Jouhikainen | President and Chief Operating Officer | $525,000 | $262,000 | 50% |
| Dave Lowrance | Chief Financial Officer | $365,000 | $128,000 | 35% |
2017 Performance Bonus Awards (Approved Dec 17, 2017):
- Rob Neville: $296,662.50
- Taneli Jouhikainen: $296,662.50
- Dave Lowrance: $108,012.50
Non-Employee Director Compensation (Effective 2018):
- Annual Board Fee: $32,000
- Meeting Fee: $2,000 per in-person meeting
- Committee Chair Fees: Audit ($17,500), Compensation ($12,500), Nominating ($7,500)
- Committee Member Fees: Audit ($7,500), Compensation ($5,500), Nominating ($3,750)
- Equity: Option to purchase 12,000 shares of common stock annually
Material Changes Versus Prior Period
Executive base salaries were increased from levels established when the executives were employed by the private predecessor entity ("Private Savara") prior to the April 2017 merger. The filing notes that compensation had not been adjusted since the merger despite the transition to a public company. Additionally, the Board approved specific 2017 performance bonuses and established a formal target bonus structure for 2018, which was not previously in place for the public entity.
Guidance, Outlook, and Risks
The filing contains no financial guidance, revenue outlook, or discussion of market risks. Management commentary indicates that the compensation program is designed to attract and retain qualified officers and align their interests with stockholders. The Board discussed but did not approve any new equity awards for executive officers at this time. Actual bonus amounts for 2018 may vary based on the achievement of corporate and individual performance goals.
Key Facts for Investor Verification
- Verify the total cash outflow impact of the approved 2017 bonuses ($701,337.50 total for the three executives) and the increased 2018 base salary obligations.
- Confirm the performance metrics tied to the 2018 target bonuses, as actual payouts are discretionary and goal-dependent.
- Review the company's cash position to ensure liquidity is sufficient to support the increased fixed compensation costs.
- Note that no new equity awards were granted to executives in this filing, though non-employee directors received stock options.